Ísrael - hebreska - Ministry of Health

אינווסט אימפקס בע"מ - רופא - אונקולוגיה + גניקולוגיה +רדיולוגיה פולשנית

Ísrael - hebreska - Ministry of Health

אגנטק (1987) בע"מ - מומחה

Ísrael - hebreska - Ministry of Health

אגנטק (1987) בע"מ - אחות - לקיחת דם עורקיורידי מפציינט במחלקת בי"ח לבדיקת גזים, אלקטרוליטים, מטבוליטים ואוקסימטריה בדם

Ísrael - hebreska - Ministry of Health

a.m.i. technologies, ltd. - רופא - מערכת למדידת החלל הפנימי של כלי דם לפני ביצוע פרוצדורה התערבותית

Ísrael - hebreska - Ministry of Health

תעשיות חלב ת.מ.ח. בע"מ - קבוצת חכמי - מומחה - קטטרים להפריה מלאכותית

Ísrael - hebreska - Ministry of Health

pfizer pharmaceuticals israel ltd - etanercept - אבקה וממס להכנת תמיסה להזרקה - etanercept 25 mg/vial - etanercept - etanercept - * rheumatoid arthritis:enbrel is indicated for the treatment of active rhematoid arthritis in adults when the response to disease-modifying antirheumatic drugs (dmards) including methotrexate (unless contraindicated) has been inadequate.. enbrel can be used in combination with methotrexate in patients who do not respond adequately to methotrexate alone. reducing signs and symptoms and inhibiting the progression of structural damage in patients with moderately to severely active rheumatoid arthritis.enbrel, alone or in combination with methotrexate, has been shown to reduce the rate of progression of joint damage as measured by x-ray and to improve physical function.* polyarticular juvenile idiopathic arthritis: treatment of active polyarticular juvenile idiopathic arthritis in children and adolescents from the age of 2 years who have had an inadequate response to, or who have proved intolerant of, methotrexate. enbrel has not been studied in children aged less than 2 years.* psoriatic arthritistreatment of ac

Ísrael - hebreska - Ministry of Health

pfizer pharmaceuticals israel ltd - etanercept - תמיסה להזרקה - etanercept 50 mg/ml - etanercept - etanercept - * rheumatoid arthritis:enbrel is indicated for the treatment of active rhematoid arthritis in adults when the response to disease-modifying antirheumatic drugs (dmards) including methotrexate (unless contraindicated) has been inadequate.. enbrel can be used in combination with methotrexate in patients who do not respond adequately to methotrexate alone. reducing signs and symptoms and inhibiting the progression of structural damage in patients with moderately to severely active rheumatoid arthritis.enbrel, alone or in combination with methotrexate, has been shown to reduce the rate of progression of joint damage as measured by x-ray and to improve physical function.* polyarticular juvenile idiopathic arthritis: treatment of active polyarticular juvenile idiopathic arthritis in children and adolescents from the age of 2 years who have had an inadequate response to, or who have proved intolerant of, methotrexate. enbrel has not been studied in children aged less than 2 years.* psoriatic arthritistreatment of ac

Ísrael - hebreska - Ministry of Health

pfizer pharmaceuticals israel ltd - etanercept - תמיסה להזרקה - etanercept 50 mg/ml - etanercept - etanercept - * rheumatoid arthritis:enbrel is indicated for the treatment of active rhematoid arthritis in adults when the response to disease-modifying antirheumatic drugs (dmards) including methotrexate (unless contraindicated) has been inadequate.. enbrel can be used in combination with methotrexate in patients who do not respond adequately to methotrexate alone. reducing signs and symptoms and inhibiting the progression of structural damage in patients with moderately to severely active rheumatoid arthritis.enbrel, alone or in combination with methotrexate, has been shown to reduce the rate of progression of joint damage as measured by x-ray and to improve physical function.* polyarticular juvenile idiopathic arthritis: treatment of active polyarticular juvenile idiopathic arthritis in children and adolescents from the age of 2 years who have had an inadequate response to, or who have proved intolerant of, methotrexate. enbrel has not been studied in children aged less than 2 years.* psoriatic arthritistreatment of ac

Ísrael - hebreska - Ministry of Health

abbott medical laboratories ltd - artificial butterscotch flavor 146 mg / 100 g; artificial vanilla 1.9 g / 100 g - powder for suspension - fat/carbohydrates/proteins/minerals/vitamins, combinations - specialized elemental nutrition with glutamine for metabolically stressed patients with gastrointestinal complications.may be used as a sole source of nutrition or as a supplement to a prescribed diet.

Ísrael - hebreska - Ministry of Health

פריגו ישראל סוכנויות בע"מ - אחר - מזרקים לבדיקות רמות גזים בדם